Low Leverage / Strong Equity BaseVery low debt and an equity ratio near 90% provide durable financial flexibility. Minimal leverage reduces refinancing and interest risk, enabling the firm to invest in product R&D or weather revenue volatility without immediate solvency pressures, supporting medium-term strategic initiatives.

High Gross MarginsSustained gross margins near 77% indicate a structurally profitable software business model with high variable margin per sale. This margin cushion supports reinvestment in product development and sales capacity, allowing the company to maintain profitability even if top-line growth is muted.

Recurring Subscription Revenue MixA material subscription and license revenue component creates predictable, recurring cash inflows and higher customer lifetime value. Over 2-6 months this stability supports revenue visibility, reduces customer concentration risk, and enables prioritizing retention and product-led growth strategies.

Bears Say

Material Revenue DeclineA >25% revenue drop signals persistent demand or execution problems that impair scalability and pricing power. If revenue contraction persists, it undermines fixed-cost absorption and the ability to fund strategic investments, making recovery slower and margins harder to sustain over the medium term.

Negative Free Cash FlowA sharp swing to deeply negative free cash flow drains liquidity and limits the company's ability to self-fund R&D or sales expansion. Over several quarters this can force asset sales, external financing, or cutbacks in strategic programs, increasing execution and refinancing risk.

Falling Profitability And ROERapid deterioration in net margin and ROE indicates worsening operating efficiency or pricing pressure. Reduced returns on shareholder capital constrain ability to attract investment, limit retained earnings for growth, and suggest structural issues in scaling profitable operations absent clear corrective measures.

5619 FAQ

What was MRSO, Inc.’s price range in the past 12 months?

MRSO, Inc. lowest stock price was ¥836.00 and its highest was ¥1280.00 in the past 12 months.

What is MRSO, Inc.’s market cap?

MRSO, Inc.’s market cap is ¥3.15B.

When is MRSO, Inc.’s upcoming earnings report date?

MRSO, Inc.’s upcoming earnings report date is May 14, 2026 which is in 87 days.

How were MRSO, Inc.’s earnings last quarter?

MRSO, Inc. released its earnings results on Feb 12, 2026. The company reported ¥4.09 earnings per share for the quarter, beating the consensus estimate of N/A by ¥4.09.

Is MRSO, Inc. overvalued?

According to Wall Street analysts MRSO, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MRSO, Inc. pay dividends?

MRSO, Inc. does not currently pay dividends.

What is MRSO, Inc.’s EPS estimate?

MRSO, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MRSO, Inc. have?

MRSO, Inc. has 3,552,750 shares outstanding.

What happened to MRSO, Inc.’s price movement after its last earnings report?

MRSO, Inc. reported an EPS of ¥4.09 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of MRSO, Inc.?

Currently, no hedge funds are holding shares in JP:5619

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

MRSO, Inc.

MRSO, Inc. operates a platform that manages reservations for medical check-ups. It offers Health Care Plat Form (HCPF), DX, and Large-scale vaccination services. HCPF service offers medical checkup and medical checkup online reservation service by MRSO.jp. DX service handles web reservation service using the homepage-based medical checkup and medical examination web reservation system (MRS). Large-scale vaccination service provides web reservation for vaccination of new type of coronavirus. The company was founded by Tsunegoro Nishino on February 6, 2015 and is headquartered in Tokyo, Japan.